TG THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
TG THERAPEUTICS, INC. (TGTX) had Additional Paid in Capital, Common Stock of $60.69 million as of 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2011-11-14
- 2011-09-30: Additional Paid in Capital, Common Stock $60.69M.
- 2011-06-30: Additional Paid in Capital, Common Stock $58.29M.
- 2010-12-31: Additional Paid in Capital, Common Stock $55.93M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2011-09-30 | $60.69M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $58.29M 10-Q/A · filed 2011-09-14 |
| 2010-12-31 | $55.93M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |